Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 

 

 

Back to index

Cancer Chemotherapy Regimen for Mesothelioma Cancer


 AC                                              mesothelioma(112)
 _________________________________________________________________
  adriamycin...... 50 mg/sqm IV day 1.
  cisplatin....... 50 mg/sqm IV day 1.
  FREQUENCY....... Repeat cycle every 3 weeks.

  reference...
    Zidar BL.  Pugh RP.  Schiffer LM.  Raju RN.  Vaidya KA. Bloom 
    RL.  Horne D.  Baker LH. Treatment of six cases of 
    mesothelioma with doxorubicin and cisplatin. Cancer.  
    52(10):1788-91, 1983 Nov 15. 
  abstract...
    Six patients with unresectable malignant mesothelioma were 
    treated with chemotherapy consisting of doxorubicin and 
    cisplatin every 3 weeks. One patient with paratesticular 
    mesothelioma metastatic to lungs entered complete remission 
    for 8 months; his disease has relapsed but he is alive 32 
    months after initiation of chemotherapy. One patient with 
    peritoneal mesothelioma achieved partial response for 12 
    months. Two patients with pleural mesothelioma achieved a 
    partial response of 5- and 6-month durations, respectively. 
    Two patients with pleural mesothelioma failed to respond to 
    this regimen. Thus, four of six patients responded to 
    doxorubicin-cisplatin chemotherapy. These preliminary results 
    merit further study and confirmation; future investigations of 
    cisplatin alone are necessary to better define the role of 
    this agent in mesothelioma. 
 

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 

 advertisement.gif (61x7 -- 0 bytes)

 

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2007 The Doctors Lounge. All rights reserved.